Quantification of diazeniumdiolate mutagenicity in four different in vitro assays

P J Donovan1, G T Smith, T E Lawlor

  • 1Laboratory of Comparative Carcinogenesis, National Cancer Institute, Frederick Cancer Research and Development Center, Maryland 21702-1201, USA.

Insights

This study assessed the mutagenic potential of two nitric oxide-releasing compounds, DEA/NO and SPER/NO. While mutagenic in bacteria, these diazeniumdiolates demonstrated significantly weaker mutagenic effects in mammalian cells.

Area of Science:

  • Pharmacology and Toxicology
  • Genetics and Molecular Biology
  • Nitric Oxide Research

Background:

  • Diazeniumdiolates are investigated as prodrugs for nitric oxide (NO), a key bioregulatory molecule.
  • Understanding the genotoxic profile of NO-releasing compounds is crucial for their therapeutic development.
  • DEA/NO and SPER/NO are diazeniumdiolates with distinct NO-release half-lives.

Purpose of the Study:

  • To evaluate the mutagenic and genotoxic potential of DEA/NO and SPER/NO in bacterial and mammalian systems.
  • To compare the genotoxicity of these compounds across different assays, including Ames test, mammalian cell gene mutation assays, and sister chromatid exchange (SCE) assay.

Main Methods:

  • Bacterial reverse mutation assay (Ames test) using Salmonella typhimurium TA1535.
  • Mammalian cell gene mutation assays: CHO/HGPRT and L5178Y TK+/-.
  • Sister chromatid exchange (SCE) assay in Chinese hamster ovary (CHO) cells.

Main Results:

  • Both DEA/NO and SPER/NO were mutagenic in Salmonella typhimurium.
  • In mammalian cells, DEA/NO showed weak mutagenicity at high concentrations in the CHO/HGPRT assay, while SPER/NO was mutagenic at 0.5 mM.
  • DEA/NO induced significant SCE in CHO cells, and SPER/NO also increased SCE, though to a lesser extent.

Conclusions:

  • The diazeniumdiolates DEA/NO and SPER/NO exhibit mutagenic activity in bacteria.
  • These compounds display considerably weaker mutagenic potential in mammalian cell-based assays compared to bacterial assays.
  • Further investigation into the specific mechanisms of genotoxicity in mammalian systems is warranted.